...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Trial
5
Aug 31, 2016 10:08PM
3
Sep 01, 2016 12:45AM
1
Sep 07, 2016 08:16AM
5
Sep 07, 2016 09:34AM

Sep 07, 2016 11:18AM
3
Sep 07, 2016 11:48AM

Sep 07, 2016 07:29PM
4
Sep 08, 2016 09:48AM

HI Bear,

The question I have pertaining to the Zen3694 trial is if they encountered Dose limiting toxicitity in any of the beginnging phases /cycle than I would think that the trial would have been stopped and a NR would been released. Since its not a double blinded trial the fact that we are near Cycle 4 of dosing and continuing the trial would be a good thing...... I am not scientist just a layman with all this science

Thanks

4
Sep 08, 2016 11:31AM
Share
New Message
Please login to post a reply